Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Cash from Investing Activities: 2019-2021

Historic Cash from Investing Activities for Black Diamond Therapeutics (BDTX) over the last 3 years, with Dec 2021 value amounting to $43.2 million.

  • Black Diamond Therapeutics' Cash from Investing Activities rose 750.45% to $43.2 million in Q4 2021 from the same period last year, while for Dec 2021 it was $130.6 million, marking a year-over-year increase of 146.37%. This contributed to the annual value of $17.0 million for FY2024, which is 3.81% up from last year.
  • According to the latest figures from Q4 2021, Black Diamond Therapeutics' Cash from Investing Activities is $43.2 million, which was up 21.14% from $35.7 million recorded in Q3 2021.
  • Black Diamond Therapeutics' Cash from Investing Activities' 5-year high stood at $48.2 million during Q2 2021, with a 5-year trough of -$279.6 million in Q2 2020.
  • Over the past 3 years, Black Diamond Therapeutics' median Cash from Investing Activities value was $2,000 (recorded in 2019), while the average stood at -$13.7 million.
  • Examining YoY changes over the last 5 years, Black Diamond Therapeutics' Cash from Investing Activities showed a top increase of 41,890.91% in 2020 and a maximum decrease of 13,982,100.00% in 2020.
  • Over the past 3 years, Black Diamond Therapeutics' Cash from Investing Activities (Quarterly) stood at -$2,000 in 2019, then plummeted by 332,300.00% to -$6.6 million in 2020, then surged by 750.45% to $43.2 million in 2021.
  • Its last three reported values are $43.2 million in Q4 2021, $35.7 million for Q3 2021, and $48.2 million during Q2 2021.